← Back to Search
Behavioural Intervention
Enhanced Assistance During Radiotherapy for Cancer (EARN Trial)
Saint Louis, MO
N/A
Recruiting
Led By Joanna Yang, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 18 years of age
Planned to receive or currently receiving a protracted course of curative-intent radiotherapy with specific fraction requirements
Must not have
Undergoing treatment for anaplastic thyroid cancer
Planned or scheduled to undergo radiotherapy simulation more than 28 days from the date of consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of radiotherapy (estimated to be 4 months)
Awards & highlights
No Placebo-Only Group
Summary
This trial is studying a new program to help patients with unmet needs who are receiving more than 10 radiation therapy sessions. They want to see if this program can help patients finish their treatment on time
See full description
Who is the study for?
This trial is for patients with various cancers, including uterine, salivary gland, head and neck, vaginal, esophageal, stomach, bladder, cervical cancer and more. Participants must be undergoing radiotherapy in over 10 sessions.Check my eligibility
What is being tested?
The study tests if enhanced assistance during radiotherapy helps patients complete their treatment without delays compared to past data on standard support.See study design
What are the potential side effects?
Since the trial compares different levels of assistance rather than medications or treatments directly affecting health conditions there are no direct side effects from interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
show original
Select...
I am undergoing or scheduled for a specific long-term radiation therapy aimed at curing my condition.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently being treated for anaplastic thyroid cancer.
show original
Select...
My radiotherapy simulation is scheduled for more than 28 days after I give consent.
show original
Select...
I am in the hospital and will not have more than 10 radiotherapy sessions as an outpatient.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through completion of radiotherapy (estimated to be 4 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of radiotherapy (estimated to be 4 months)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Delay-free completion of radiotherapy
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Standard Assistance + Enhanced AssistanceExperimental Treatment2 Interventions
In the time period that patients are receiving radiotherapy, study participants will receive standard plus enhanced financial assistance for unmet essential needs.
Find a Location
Closest Location:Washington University School of Medicine· Saint Louis, MO
Who is running the clinical trial?
American Society of Clinical OncologyOTHER
38 Previous Clinical Trials
148,124 Total Patients Enrolled
Washington University School of MedicineLead Sponsor
2,023 Previous Clinical Trials
2,352,167 Total Patients Enrolled
Joanna Yang, M.D.Principal InvestigatorWashington University School of Medicine